These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9142121)
1. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Boyer JD; Ugen KE; Wang B; Agadjanyan M; Gilbert L; Bagarazzi ML; Chattergoon M; Frost P; Javadian A; Williams WV; Refaeli Y; Ciccarelli RB; McCallus D; Coney L; Weiner DB Nat Med; 1997 May; 3(5):526-32. PubMed ID: 9142121 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638 [TBL] [Abstract][Full Text] [Related]
3. DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees. Boyer JD; Ugen KE; Chattergoon M; Wang B; Shah A; Agadjanyan M; Bagarazzi ML; Javadian A; Carrano R; Coney L; Williams WV; Weiner DB J Infect Dis; 1997 Dec; 176(6):1501-9. PubMed ID: 9395361 [TBL] [Abstract][Full Text] [Related]
4. Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. el-Amad Z; Murthy KK; Higgins K; Cobb EK; Haigwood NL; Levy JA; Steimer KS AIDS; 1995 Dec; 9(12):1313-22. PubMed ID: 8605050 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. Boyer JD; Chattergoon M; Shah A; Ginsberg R; MacGregor RR; Weiner DB Dev Biol Stand; 1998; 95():147-53. PubMed ID: 9855425 [TBL] [Abstract][Full Text] [Related]
6. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Ugen KE; Boyer JD; Wang B; Bagarazzi M; Javadian A; Frost P; Merva MM; Agadjanyan MG; Nyland S; Williams WV; Coney L; Ciccarelli R; Weiner DB Vaccine; 1997 Jun; 15(8):927-30. PubMed ID: 9234550 [TBL] [Abstract][Full Text] [Related]
7. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees. Bagarazzi ML; Boyer JD; Ugen KE; Javadian MA; Chattergoon M; Shah A; Bennett M; Ciccarelli R; Carrano R; Coney L; Weiner DB Vaccine; 1998 Nov; 16(19):1836-41. PubMed ID: 9795389 [TBL] [Abstract][Full Text] [Related]
9. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines. zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276 [TBL] [Abstract][Full Text] [Related]
10. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230 [TBL] [Abstract][Full Text] [Related]
11. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. Boyer JD; Wang B; Ugen KE; Agadjanyan M; Javadian A; Frost P; Dang K; Carrano RA; Ciccarelli R; Coney L; Williams WV; Weiner DB J Med Primatol; 1996 Jun; 25(3):242-50. PubMed ID: 8892046 [TBL] [Abstract][Full Text] [Related]
16. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P). Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268 [TBL] [Abstract][Full Text] [Related]
18. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793 [TBL] [Abstract][Full Text] [Related]
19. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Yin J; Dai A; Lecureux J; Arango T; Kutzler MA; Yan J; Lewis MG; Khan A; Sardesai NY; Montefiore D; Ruprecht R; Weiner DB; Boyer JD Vaccine; 2011 Sep; 29(39):6763-70. PubMed ID: 21195801 [TBL] [Abstract][Full Text] [Related]
20. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques. Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]